Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced the launch of a U.S. Expanded Access Program (EAP) for up to 250 adults with post-bariatric hypoglycemia (PBH) ...

Amazon is launching a new GLP-1 program through One Medical and Amazon Pharmacy to streamline access to popular weight-loss drugs.

Proponents of medicinal hemp and medical marijuana are generally pleased with the pilot program launched in April by CMS to ...

Through Amazon Pharmacy, patients will be able to access medications including Novo Nordisk's Wegovy as well as newer oral GLP-1 options.